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Association between obesity and craniofacial muscles 
sensitivity: an experimental study in pain-free subjects
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Abstract: The objective of this study was to investigate if any association exists between obesity and muscle sensitiv-
ity in the craniofacial region of healthy individuals with different body mass index (BMI). The study was designed as 
a parallel single blinded investigation approved by the North Denmark Region Committee on Health Research Ethics 
(N-20180029). Written informed consent was obtained from all participants. Subjects were divided into normal 
BMI (18.5-24.9 kg/m2) and high BMI (≥25.0 kg/m2). Measurement of body composition parameters was followed 
by pressure algometry applied on skin overlying masseter and temporalis muscles before and after a cold pressor 
test (CPT). Deltoid muscle was used as a reference point. Statistical analysis was carried out to investigate the 
difference in mean pressure pain threshold (PPT) values and the conditioned pain modulation (CPM) effect. Forty 
subjects were included (20 normal BMI and 20 high BMI). No significant difference was found in mean PPT values 
or mean CPM effect between the BMI groups (PPT: masseter P=0.763, temporalis P=0.425, deltoid P=0.595 and 
CPM effect: masseter P=0.396, temporalis P=0.463, deltoid P=0.484). Mechanical muscle sensitivity and CPM ef-
fect were sex-independent. No influence of BMI was identified on mechanical muscle sensitivity in the craniofacial 
region of healthy individuals.
Keywords: Obesity, body mass index, craniofacial muscles, pain threshold, pain sensitivity
Introduction 
Overweight and obesity are considered multi-
factorial, complex, and common conditions, 
which affect more than two billion adults glob-
ally [1, 2]. In 2016, the World Health Organizati- 
on (WHO) stated that 39% of all adults world-
wide were overweight, while 13% were people 
with obesity [3, 4]. In the Scandinavian coun-
tries, these conditions are escalating as well, 
and here the prevalence is even higher with 
40-60% [3, 5, 6]. 
The WHO describes overweight and obesity as: 
“An abnormal or excessive fat accumulation 
that presents a risk to health” [6]. They are usu-
ally defined by the Body Mass Index (BMI), 
which is a fast, inexpensive, and easy method 
when assessing overweight and obesity [6]. A 
normal BMI is between 18.5 kg/m2 and 24.9 
kg/m2, whereas a BMI between 25.0 kg/m2 
and 29.9 kg/m2 is classified as overweight, 
and a BMI equal to or greater than 30.0 kg/m2 
is considered an obesity status [6-8]. Since BMI 
does not differentiate between excess fat, lean 
mass, age, and gender, alternative measure-
ments such as the waist-to-hip ratio (WHR) and 
body fat percentage are proposed more accu-
rate measures to adjust for different body types 
[1, 7, 9].
Overweight and obesity have a negative impact 
on most physiological and biological systems, 
which eventually leads to several other condi-
tions such as diabetes, cardiovascular, and 
musculoskeletal disorders [10, 11]. Pain has 
also been shown highly associated with obesity 
[12-14], and it is well known that overweight, 
obesity, and pain all reduce life-quality, and are 
considered some of the most costly medical 
problems for society, indicating an important 
need for further intervention to reverse this 
development [6, 15]. The cause-effect relation 
between obesity and pain is not known [12, 16], 
although several relations have been proposed 
[12, 16, 17]. One relation states that mechani-
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cal loading contributes to tissue damage in 
weight bearing joints, leading to pain in individ-
uals with obesity [12, 16, 17]. Another pro-
posed mechanism with an effect on the central 
nociceptive transmission is systemic inflamma-
tion, which might explain the occurrence of 
pain conditions where weight-bearing joints are 
not involved [17]. Excess accumulation of fat 
occurs in overweight and individuals with obe-
sity, macrophages enter the adipose tissues, 
resulting in elevated levels of cytokines, espe-
cially interleukin (IL)-6, IL-1β, and tumor necro-
sis factor-α, which mediate a systemic inflam-
matory state [11, 17, 18]. Elevated levels of IL-6 
have been shown in different pain conditions 
such as Tension Type Headache (TTH) and 
fibromyalgia, leading to aggravation of chronic 
pain [19]. The systemic inflammatory state is 
proposed in the literature leading to an increase 
of general pain sensitivity in both overweight 
and obese individuals [17]. Few studies have 
investigated the relation between obesity and 
craniofacial muscle sensitivity, which may be 
related to the increased systemic inflammatory 
state, but further research is needed to clarify 
[18, 20]. A cause-effect relation could provide 
better pain management in patients suffering 
from craniofacial pain leading to increased 
life-quality. 
A study by Tashani et al. indicated that individu-
als with obesity are more sensitive to mechani-
cal stimuli than non-obese individuals, demon-
strating that BMI and body fat both influence 
pain sensitivity in proportion to pressure pain 
but not to thermal pain [21]. The measurement 
sites included skin over the thenar eminence, 
and skin at the suprailiac above the crest of the 
ilium [21]. On the contrary, Price et al. found no 
difference between obese and non-obese indi-
viduals regarding pain sensitivity on the hand 
and the forehead, i.e. regions with no excessive 
subcutaneous fat, when inducing thermal and 
mechanical pain stimuli [22]. To the best of the 
researchers’ knowledge, no other studies inve- 
stigating mechanical muscle sensitivity in the 
craniofacial region have yet been carried out. 
Consequently, further research is needed due 
to the inconsistency in the literature, as well as 
the importance of identifying a possible link 
between craniofacial pain and obesity, in order 
for clinicians to provide better pain manage-
ment. Therefore, the current study aimed to 
investigate the association between obesity 
and mechanical muscle sensitivity in a non-
weightbearing region, the masseter, and tem-
poralis muscles, of healthy individuals. Pres- 
sure algometry was used on skin overlying 
these muscles to determine mechanical mus-
cle sensitivity before and after a cold pressor 
test (CPT).
It was hypothesized that 1) mechanical muscle 
sensitivity is higher in individuals with a BMI 
≥25.0 kg/m2; and 2) the conditioned pain mod-
ulation (CPM) effect is decreased in individuals 
with a BMI ≥25.0 kg/m2 compared to individu-
als with a normal BMI (18.5-24.9 kg/m2).
Material and methods
A parallel group investigator-blinded study was 
designed to test the hypotheses in healthy sub-
jects with different BMIs. The study was appr- 
oved by the North Denmark Region Committee 
on Health Research Ethics (N20180029), and 
carried out according to the Declaration of 
Helsinki [23].
Subjects
The sample size of this study was calculated 
with the effect size identified by Tashani et al. 
who applied a similar methodology [21]. Healthy 
subjects were recruited via online advertise-
ment (Forsoegsperson.dk and Facebook.com) 
and through notices at Aalborg University and 
at other public institutions. Subjects express- 
ing interest to participate in the study received 
additional information with sufficient time to 
consider participation. Written informed con-
sent was obtained with giving right to withdraw 
from the study at any given time without any 
consequence. Included subjects were healthy 
men and women of 18-65 years, non-smokers, 
Caucasian, and with a BMI ≥18.5 kg/m2. Sub- 
jects were excluded if they were pregnant or 
breastfeeding; had pacemaker; had full-grown 
beard; lacked the ability to cooperate; perfo- 
rmed extreme athletic activities (e.g., bodybu- 
ilding); were affected by any neurological, car-
diovascular, musculoskeletal, or psychological 
illnesses; suffered from craniofacial pain, mi- 
graine, chronic TTH, new daily persistent head-
ache, or Temporomandibular Disorders (TMD); 
had dermatological skin conditions, wounds, 
scars, or skin sensation alteration (e.g., due to 
a past trauma or operation) in the facial region; 
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experienced chronic pain within the last 3 
months or acute pain on the day of the study 
session; had flu or fever within the last 2 weeks; 
were addicted to drugs defined as the use of 
cannabis, opioids, or other drugs; consumed 
alcohol within the last 24 hours; used medica-
tion with impact on the immune system or pain 
for the last 24 hours, or currently used supple-
ments and medication that are known to affect 
body weight. Subjects were divided into two 
groups according to their BMI, high BMI (≥25.0 
kg/m2) and a normal BMI (18.5-24.9 kg/m2).
Experimental procedure
The experimental session took place in a quiet, 
spacious, bright room, with a table, two chairs 
without armrests and wheels, and a blank wall. 
The session included 5 steps and lasted ap- 
proximately 60 minutes. Body composition pa- 
rameters were obtained first and followed by 
PPT assessment before and after the Cold 
pressor test (CPT) (Figure 1). All procedures 
were performed according to standard operat-
ing procedures. All data were recorded in case 
report forms. 
Measurement of body composition parameters
Body composition parameters were measured 
to classify the subjects into two groups, where 
BMI was used to divide the subjects. Additional 
parameters were obtained to support the clas-
sification. Participants were instructed to wear 
a loose shirt and a pair of pants when body 
composition parameters were obtained. Body 
fat percentage and weight were determined 
with a SilverCrest Diagnostic Scale (Targa GM- 
BH, Soest, Germany), which estimates body fat 
percentage using bioelectrical impedance anal-
ysis [7]. Height was measured using a non-elas-
tic measuring tape while the subject was posi-
tioned with heels, buttocks, and head against 
the wall standing on bare feet. Waist circumfer-
ence was measured with a measuring tape 
placed at the midpoint between the last rib and 
the upper edge of the iliac crest, and the hip 
circumference was assessed around the mid-
line of the greater trochanter. WHR was calcu-
lated as waist circumference (cm) divided by 
hip circumference (cm), while Waist-to-height 
ratio (WHtR) was calculated as waist circumfer-
ence (cm) divided by height (cm), and BMI (kg/
Figure 1. Time-frame of the study session and performed procedures.
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m2) was determined as the weight (kg) divided 
by the square of the height (m2) [7].
Pressure algometry
Muscle sensitivity to mechanical pressure was 
assessed by measuring PPT, one of the quanti-
tative sensory tests (QST) [24]. PPT has been 
altered in a number of conditions such as TMD 
and TTH and it is considered a valuable mea-
sure of muscle sensitivity [25-27].
PPT (kPa) was assessed with a handheld pres-
sure algometer (Somedic Senselab, Sosdala, 
Sweden), that could deliver mechanical pres-
sure under controlled conditions with a prede-
termined slope (30 kPa/sec) [28]. The algome-
ter was equipped with a rubber tip of 1 cm2, 
which was placed perpendicularly on the skin 
overlying the targeted muscles. The device was 
calibrated before the study. To define PPT, the 
subjects were instructed to press a stop button 
with their dominant hand as soon as the pres-
sure turned into a sensation of pain [29]. The 
PPT was measured twice, before and after 
application of CPT, on the skin overlying tempo-
ralis, masseter, and deltoid muscles in both 
right and left sides. The anterior part of the 
temporalis muscle and the lower prominent 
region of the masseter muscle were identified 
by palpation when the subject clenched the 
teeth. The deltoid muscle was identified five cm 
below the middle tip of the shoulder, and used 
as a reference point [30]. The skin surface of 
the identified muscles were marked with a 
small piece of 3M medical tape. The PPT was 
measured three times for those six muscles, 
without stimulating the same muscle twice in a 
row. This process ensured that a sufficient 
washout period was considered between pr- 
essure application that may cause temporal 
summation and muscle sensitization [31]. Fur- 
thermore, investigator variability was reduced, 
as the mean of three measurements from the 
same muscle was used for further analysis 
[32].
Cold pressor test
The function of descending inhibitory pain path-
ways [33] can be investigated experimentally 
using conditioned pain modulation (CPM), in 
which a secondary pain stimulus is applied to 
see how it affects the pain sensitivity to a pri-
mary pain stimulus [26, 34]. The importance of 
investigating the descending inhibitory path-
ways is that in some pain disorders, such as 
TTH, TMD, and chronic pain in general, the 
activity of the descending inhibitory pathways 
has been impaired, resulting in a higher pain 
sensitivity in affected individuals [26, 34, 35]. 
CPT is one of the tests that is commonly used 
to investigate the CPM effect under experim- 
ental conditions [15]. The CPM effect was de- 
fined as the difference between PPT values 
before and after the CPT. Subjects were in- 
structed to immerse their non-dominant hand 
up to the wrist in cold water of approximately 
1-4°C for 2 minutes [22, 36]. The subjects were 
encouraged to keep the hand still during the 
two minutes. Two minutes were chosen for the 
CPT, to reduce the risk of tissue damage [37]. 
The sensation of cold pain was rated by the 
subjects on a Visual Analogue Scale (VAS) from 
0: “No pain” to 10: “Worst imaginable pain”. 
The VAS was rated 2 minutes after immersing 
the hand in the cold water, at the end of the 
CPT. If the pain was unbearable, the subjects 
were allowed to remove the hand from the cold 
water before time was up and the VAS was 
rated immediately.
Statistical analysis
Data were presented as arithmetic means ± 
standard deviation (SD). Graphs were prepared 
using Excel 2013 (Microsoft Office Professional 
Plus 2013, version 15.0.4981.1001, Redmond, 
Washington, USA) and flowcharts were created 
using Lucidchart 2018 (Lucid Software Inc., 
South Jordan, Utah, USA). All statistics were 
performed using the Statistical Package for 
Social Sciences software (IBM SPSS, version 
25, Armonk, New York, USA).
Shapiro Wilk’s test was used to assess if data 
were normally distributed, where p-values 
≥0.05 were considered significant.
To evaluate if there was a significant difference 
in the BMI values between the two BMI groups, 
and to compare additional body composition 
measures between the groups, a one-way 
Analysis of Variance (ANOVA) was performed for 
normal distributed data while a Kruskal-Wallis 
test was performed for the non-normal distrib-
uted data. 
A Repeated Measures ANOVA with pairwise 
comparison was carried out to examine if data 
of the craniofacial muscles could be pooled for 
further statistical tests. In addition, Wilcoxon’s 
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signed rank test was performed to investigate 
if the data from the left and right deltoid mus-
cle could be pooled. Additionally, paired t-tests 
were run to see if the CPT could provoke the 
CPM effect in each muscle for all subjects, 
regardless of BMI and sex.
To examine the effect of BMI and sex on PPT 
values, a two-way ANOVA was carried out for 
the temporalis and masseter muscles. Equally, 
a two-way ANOVA was performed on log-trans-
formed data for the deltoid muscle. To examine 
the effect of BMI and sex on the CPM effect, a 
two-way ANOVA was carried out for the data of 
the percentage change in the PPT (from before 
the CPT to after the CPT).
Mauchly’s test of sphericity and Levene’s test 
for equality of variances were performed to 
ensure the assumptions of the statistical tests 
were met. All ANOVAs were considered signifi-
cant at a p-value ≤0.05.
Correlational analyses were carried out to 
investigate potential correlation between BMI 
values and PPT before CPT, and between VAS 
scores and the CPM effect for each muscle. 
Additionally, correlational analysis was used to 
test if the obtained body composition parame-
ters were consistent. Pearson’s correlation was 
applied for parametric data, whereas Spear- 
man’s rank correlation was used for non-para-
metric data. Correlation coefficients were eval-
0.001, P<0.001, P=0.002, P=0.015, P=0.008, 
P<0.001, respectively); hence, the non-para-
metric Kruskal-Wallis test was applied to test 
the difference between the BMI groups. Equally, 
a one-way ANOVA was applied for the normally 
distributed data of height and WHR (P=0.838, 
P=0.504, respectively). The tests revealed sig-
nificant differences between the two BMI 
groups for weight (P<0.001), waist circumfer-
ence (P<0.001), hip circumference (P<0.001), 
body fat percentage (P<0.001), BMI (P<0.001), 
WHtR (P<0.001), and WHR (P=0.001). There 
were no significant differences between groups 
for age (P=0.099) and height (P=0.865) (Table 
1).
The normal BMI group included 10 males and 
10 females, with a mean BMI of 22.83±1.70 
kg/m2 and a mean age of 23.30±1.81 years 
within a range of 20-27 years. The other group 
included subjects with a high BMI and consist-
ed of 10 females and 10 males. In the high BMI 
group, the mean BMI was 33.65±8.91 kg/m2, 
and the mean age was 27.05±8.53 years with-
in a range of 20-51 years. The scale was not 
able to measure the weight for one subject in 
the high BMI group due to subject’s weight 
exceeding the scale capacity; therefore, the 
subject’s self-reported weight was used to cal-
culate the BMI. For this subject the body fat 
percentage could not be obtained and there-
fore the subject was excluded from analysis of 
Figure 2. Fifty-three subjects were screened; 13 subjects were excluded and 
40 subjects were included in the study and grouped based on Body Mass 
Index (BMI).
uated according to Evans R 
classification [38].
Results
Subjects
Fifty-three subjects were scr- 
eened, and 40 subjects were 
included in the study after ex- 
clusion of 13 (Figure 2). Recr- 
uited participants finished the 
experimental session and no 
safety issue was reported or 
recorded. Included subjects 
were divided into groups ac- 
cording to their BMI. 
The distribution of BMIs, WH- 
tR, waist circumference, hip 
circumference, weight, and bo- 
dy fat percentage did not fo- 
llow normal distribution (P< 
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parameters in which body fat percentage was 
required.
Craniofacial muscle sensitivity
All mean PPT values in the craniofacial region 
were normally distributed (masseter P=0.791, 
temporalis P=0.112). Data for craniofacial mu- 
scles could not be pooled, as the mean PPT of 
the left masseter muscle was significantly dif-
ferent from both the left and right temporalis 
muscles (P=0.001 and P=0.000, respectively). 
Repeated measures ANOVA showed no differ-
ence between left and right masseter muscles 
(P=0.910) or the left and right temporalis mus-
cles (P=1.000). This finding allowed pooling of 
data from right and left side of each muscle.
In subjects with a high BMI, the mean PPT val-
ues of masseter and temporalis muscles were 
158.69±57.15 kPa and 188.29±75.44 kPa, 
respectively. In subjects with a normal BMI, the 
mean PPT value for the masseter muscle was 
153.17±59.30 kPa and 169.03±75.69 kPa for 
the temporalis muscle. The two-way ANOVA for 
the masseter and temporalis muscles yielded 
no significant differences in muscle sensitivity 
between the BMI groups (masseter P=0.763, 
temporalis P=0.425). Similarly, no significant 
differences in the muscle sensitivity were found 
between males and females, irrespective of 
BMI (masseter P=0.169, temporalis P=0.182). 
Deltoid muscle sensitivity
The mean PPT value of the deltoid muscle was 
276.69±134.63 kPa in subjects with a high 
BMI and 254.19±113.87 kPa in subjects with a 
normal BMI. The mean PPT values for the left 
(P=0.014) and right (P=0.028) deltoid muscles 
ances could be assumed (P=0.414). A two-way 
ANOVA revealed no significant difference in the 
PPT before CPT between the BMI groups (P= 
0.595). Furthermore, there was no significant 
difference in the PPT before CPT between 
males and females (P=0.086).
The CPM effect
The mean temperature of the water bath for 
CPT was monitored and was registered as 
5.50±1.12°C before the CPT and 5.99±1.28°C 
after the CPT. All participants felt cold pain and 
rated pain on the VAS (mean score: 6.18±2.03).
CPT was used to test the CPM effect. The CPM 
effect was calculated as the percentage change 
in PPT values obtained from before CPT to 
those obtained after the CPT. This was done to 
examine the functioning or alterations in de- 
scending inhibitory pain pathways (Figure 3). 
Shapiro Wilk’s test of normality showed that 
PPT values before the CPT (masseter P=0.791, 
temporalis P=0.112) and after the CPT (mas-
seter P=0.138, temporalis P=0.158) for mas-
seter and temporalis muscles followed normal 
distribution, while PPT values before the CPT 
(P=0.014) and after the CPT (P=0.12) for the 
deltoid muscle were not normally distributed. 
The percentage change in PPT before CPT to 
after the CPT followed normal distribution for 
all muscles (masseter P=1.000, temporalis 
P=0.221, deltoid P=0.854). 
The mean PPT value was higher after the CPT 
than those obtained before CPT for all exam-
ined muscles, and paired t-tests and the Wil- 
coxon’s signed rank test showed that the diff- 
erence in mean PPT was significant (masse- 
ter P=0.006, temporalis P<0.001, deltoid P< 
0.001).
Table 1. Characteristics of participants according to BMI groups
Body composition parameter Normal BMI group (mean ± SD)
High BMI group 
(mean ± SD) p-value
Height (cm) 174.43±11.17 174.97±8.85 0.865
Weight (kg) 69.94±11.37 103.63±31.97 <0.001*
Waist circumference (cm) 77.03±8.27 102.55±20.49 <0.001*
Hip circumference (cm) 98.25±8.98 118.26±17.55 <0.001*
Body fat percentage1 22.38±2.41 35.02±11.43 <0.001*
BMI (kg/m2) 22.83±1.70 33.65±8.91 <0.001*
WHtR 0.46±0.84 0.59±0.11 <0.001*
WHR 0.78±0.06 0.86±0.08 0.001*
1: Body fat percentage was calculated for 19 subjects in the high BMI group. *: signifi-
cant at a 0.05 significance level. BMI: body mass index, WHtR: waist-to-height ratio, 
WHR: waist-to-hip ratio, SD: standard deviation.
did not follow a normal dis-
tribution. Wilcoxon’s signed 
rank test showed no signi- 
ficant difference between 
left and right deltoid mus-
cles (P=0.727) and there-
fore data were pooled.
Data for the deltoid muscle 
were not normally distribut-
ed and equal variances co- 
uld not be assumed. The- 
refore, data for the deltoid 
muscle were log transform- 
ed. The log-transformed da- 
ta were normally distributed 
(P=0.207) and equal vari-
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The two-way ANOVA revealed no significant dif-
ferences in the CPM effect between the two 
BMI groups for both the craniofacial and delto- 
id muscles (masseter P=0.396, temporalis P= 
0.463, deltoid P=0.484). Similarly, there were 
no significant differences in the CPM effect 
between males and females for the craniofacial 
and deltoid muscles (masseter P=0.706, tem-
poralis P=0.831, deltoid P=0.901) (Figure 
3A-C).
Correlation analysis 
Correlational analysis was conducted in order 
to detect potential correlation between cranio-
facial muscle sensitivity, WHtR, WHR, body fat 
percentage and BMI, and between the CPM 
effect and VAS score (Table 2). Correlational 
might be a consequence of a relatively small 
sample size of this study. Based on current ob- 
tained data, only tendencies could be revealed. 
More experiments are required to find whether 
a true statistically significant difference exists 
between the subgroups. This is in particular rel-
evant for the high BMI group, in which the BMI 
variation was greater. Considering the explor-
ative nature of this pilot study, findings are dis-
cussed in the following to highlight the value 
and novelty of this study and also to provide 
further insights for next investigation.  
Association between BMI and craniofacial me-
chanical muscle sensitivity
The relation between BMI and mechanical 
muscle sensitivity of the temporalis and mas-
Figure 3. The percentage change in pressure pain threshold (PPT) from before the cold pressor test (CPT) to after 
CPT for A: temporalis, B: masseter, and C: deltoid muscles for subjects with a normal Body Mass Index (BMI) and a 
high BMI.
Table 2. Correlational analysis between various factors
Correlated factors Correlation coefficient (r) p-value
BMI and body fat percentage 0.778 <0.001*
BMI and WHtR 0.836 <0.001*
BMI and WHR 0.621 <0.001*
BMI and PPT before CPT (masseter) 0.064 0.693
BMI and PPT before CPT (temporalis) 0.134 0.979
BMI and PPT before CPT (deltoid) 0.089 0.584
VAS score and CPM effect (masseter) 0.204  0.206
VAS score and CPM effect (temporalis) 0.250 0.120
VAS score and CPM effect (deltoid) -0.051 0.753
*: significant at a 0.05 significance level. r: correlation coefficient, BMI: 
body mass index, VAS: visual analogue scale, WHtR: waist-to-height 
ratio, WHR: waist-to-hip ratio, PPT: pressure pain threshold, CPM: condi-
tioned pain modulation.
analysis revealed strong, positive cor-
relations between BMI and WHR (r= 
0.621, P<0.001), between BMI and WH- 
tR (r=0.836, P<0.001), and between 
BMI and body fat percentage (r=0.778, 
P<0.001) for all subjects. Weak corre-
lations were found between other fac-
tors (Table 2).
Discussion 
This study investigated craniofacial 
muscle sensitivity in high and normal 
BMI pain-free individuals. Although fin- 
dings provided more knowledge about 
BMI effect on pain sensitivity, variati- 
ons in mechanical thresholds were 
large enough to block indicating a clear 
association if it was exixted and this 
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seter muscles was investigated and no signifi-
cant association was found. This finding is con-
sistent with previous findings from Price et al., 
who found no significant difference between 
individuals with obesity and normal weight par-
ticipants, when measuring PPT on the forehead 
[22]. It seems that this outcome is body-site 
dependent, since Tashani et al. found that indi-
viduals with obesity had a lower PPT compared 
to normal weight individuals when investigated 
on the hand [21]. Similarly, other studies have 
demonstrated an association between pain 
and obesity, in places with increased mechani-
cal loading [12, 17]. Results from the current 
study indicate that a similar association is not 
present when muscle sensitivity is assessed in 
places without mechanical loading, such as the 
masseter and temporalis muscles. The deltoid 
muscle was also assessed in this study as a 
reference point outside the craniofacial region. 
No significant association between deltoid 
muscle sensitivity and BMI was found either. 
These results indicate that the sensory thresh-
old might not generally be decreased in over-
weight and obese individuals, but that other 
mechanisms potentially impact the pain mech-
anisms if any association exists.
Although no significant differences in pain sen-
sitivity were found between the groups, a 
Mann-Whitney U test showed a significant dif-
ference between mean BMIs in the groups. This 
indicates that the two groups were recogniz-
able. Therefore, BMI-associated muscle sensi-
tivity might be body-region dependent. Further 
investigation to measure pain sensitivity at dif-
ferent body regions would substantiate the 
findings. 
The study by Price et al. found a difference in 
pain sensitivity between individuals with obesi-
ty and normal weight participants in places 
with excessive fat accumulation, indicating that 
the association possibly exists in places with 
non-mechanical loading and excess of fat [22]. 
The direction of the possible association rema- 
ins uncertain, as Price et al. found a decreased 
pain sensitivity in individuals with obesity, when 
investigating PPT on the abdomen [22]. This is 
contrary to the hypothesis of the current study 
and other previous findings of an association 
between pain and obesity in general [12, 17, 
21]. Therefore, future studies that assess body 
fat distribution at test regions would be highly 
beneficial. In addition, identification of circulat-
ing biomarkers of pain and inflammation, e.g., 
cytokines levels in biological fluids, would faci- 
litate understanding of mechanisms underlying 
obesity-pain association. This would show wh- 
ether a systemic generalized condition exists, 
or body sites and fat layers can play a major 
role in regional pain sensitivity as it has been 
found in some studies. 
Pain sensitivity is affected by CPM, a mecha-
nism which is found to be impaired in some 
chronic pain conditions (e.g., headaches) lead-
ing to increased pain sensitivity [26, 34].
In addition to testing ascending pain pathways 
and sensitivity to mechanical stimuli, the cur-
rent study investigated responsiveness of de- 
scending inhibitory pain pathways by applica-
tion of CPT and measurement of CPM effect. 
No difference in the CPM effect was identified 
between individuals with normal and high BMI. 
Skovbjerg et al. [35] who assessed PPT (over 
tibialis anterior muscle and the upper trapezius 
muscle) and CPM effect in a large sample of 
Danish population, however identified decrea- 
sed CPM effect and increased pain sensitivity 
in females. Results from our study are not com-
parable with this study mainly due to the differ-
ence in body region selected for the assess-
ments. Our findings revealed that high BMI 
might not affect the efficiency of the mecha-
nisms underlying the CPM effect since an effi-
cient CPM effect was evident in all healthy par-
ticipants regardless of BMI.
Sex- and age-related responses
The current study did not reveal any sex-related 
responses in any of the outcomes. This is sim- 
ilar to previous findings from Rolke et al., who 
also carried out thermal and mechanical QST in 
the facial region of healthy subjects, and found 
no differences between sexes [39]. However, 
other investigators are pointing towards a high-
er pain sensitivity to experimentally induced 
pain in females. Sex-related responses might 
be due to several factors such as biological, 
social, and psychological factors [40]. The dif-
ference in the CPM effect between males and 
females was also investigated in this study, 
where no significant differences were found. 
This is inconsistent with the findings from 
Skovbjerg et al., who found a lower CPM effect 
in females than in males, indicating the exis-
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tence of a difference in the CPM effect between 
sexes [35]. The efficacy of the CPM effect is 
suggested to be age-related in women, as high-
er pain sensitivity was found in relation to lower 
estrogen levels in the normal menstrual cycle 
[40, 41]. During menopause, estrogen levels 
decrease, suggesting that pain sensitivity 
might increase with age in females [42]. The 
subjects included by Skovbjerg et al. [35] had a 
mean age of 50.7 years, which is markedly 
higher than the mean age of subjects in the 
present study. In addition, Skovbjerg et al. [35] 
found that subjects above 40 years had a high-
er PPT than those under 40 years. Since the 
age range in the present study was wider in the 
high BMI group compared to the normal BMI 
group, this might explain why no significant dif-
ference in PPT was found between the groups. 
Likewise, the sample size was larger in the pre-
vious study, emphasizing that a bigger sample 
size in the current study could possibly have 
shown that responses can be sex-dependent. 
In the present study, the age range was wider in 
the high BMI group compared to the normal 
BMI group. This might explain why no significant 
difference in PPT was found between the gr- 
oups, since Skovbjerg et al. [35] found that su- 
bjects above 40 years had a higher PPT than 
those under 40 years. Therefore, further rese- 
arch is needed to clarify if BMI, age and sex 
interact with craniofacial mechanical muscle 
sensitivity.
Conclusion
Findings revealed no significant difference in 
craniofacial mechanical muscle sensitivity be- 
tween normal and high BMI pain-free individu-
als regardless of sex.
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